We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

46 hedge funds and large institutions have $49.8M invested in InVivo Therapeutics Holdings Corp in 2016 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 0 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more call options, than puts

Call options by funds: $5.79M | Put options by funds: $2.57M

100% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 8

26% more capital invested

Capital invested by funds: $39.5M → $49.8M (+$10.4M)

21% more funds holding

Funds holding: 38 → 46 (+8)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
46
Holders Change
+8
Holders Change %
+21.05%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
13
Reduced
–
Closed
8
Calls
$5.79M
Puts
$2.57M
Net Calls
+$3.22M
Net Calls Change
+$1.68M

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$3.11M
2
BBA
Baker Bros. Advisors
New York
+$2.25M
3
Goldman Sachs
Goldman Sachs
New York
+$1.5M
4
BFA
BlackRock Fund Advisors
California
+$644K
5
BCM
Bridgeway Capital Management
Texas
+$536K

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$737K
2
Group One Trading
Group One Trading
Illinois
-$322K
3
Stifel Financial
Stifel Financial
Missouri
-$268K
4
LCM
Landscape Capital Management
New Jersey
-$213K
5
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
-$151K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
26
Citigroup
New York
$188K +$107K +1 New
RJA
27
Raymond James & Associates
Florida
$184K +$107K +1 New
RhumbLine Advisers
28
RhumbLine Advisers
Massachusetts
$176K – – –
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$169K – – –
HighTower Advisors
30
HighTower Advisors
Illinois
$164K +$107K +1 New
NFA
31
Nationwide Fund Advisors
Ohio
$143K – – –
SG Americas Securities
32
SG Americas Securities
New York
$143K +$107K +1 New
State Board of Administration of Florida Retirement System
33
State Board of Administration of Florida Retirement System
Florida
$132K – – –
Manulife (Manufacturers Life Insurance)
34
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$131K – – –
AIM
35
Alambic Investment Management
California
$126K – – –
AIG
36
American International Group
New York
$126K – – –
VKH
37
Virtu KCG Holdings
New York
$126K +$107K +1 New
BA
38
BlackRock Advisors
Delaware
$115K +$107K +1 New
VOYA Investment Management
39
VOYA Investment Management
Georgia
$102K – – –
ITIM
40
Indiana Trust & Investment Management
Indiana
$92K +$107K +1 New
CS
41
Credit Suisse
Switzerland
$86K +$107K +1 New
HKIM
42
Hayek Kallen Investment Management
Alabama
$84K – – –
Wells Fargo
43
Wells Fargo
California
$81K +$107K +1 New
Cambridge Investment Research Advisors
44
Cambridge Investment Research Advisors
Iowa
$73K – – –
SSA
45
Schonfeld Strategic Advisors
New York
$70K +$107K +1 New
Bank of America
46
Bank of America
North Carolina
$61K -$107K -1 Closed
Creative Planning
47
Creative Planning
Kansas
$38K – – –
EWM
48
Edge Wealth Management
New York
$21K – – –
LTFS
49
Ladenburg Thalmann Financial Services
Florida
$19K – – –
BlackRock
50
BlackRock
New York
$13K – – –
1
2
3

NVIV Hedge Fund Activity: Q1 2016 in Review

46 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q1 2016, worth a combined $49.8M — up 26% from $39.5M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new NVIV positions and 8 closed out — a net gain of 8 holders — while 13 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $3.11M. The largest seller was Wellington Management Group, exiting entirely with an estimated $737K sold.

  • 46 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q1 2016, up from 38 in Q4 2015.
  • Funds reported $49.8M of InVivo Therapeutics Holdings Corp stock for Q1 2016, up 26% quarter-over-quarter.
  • 16 funds opened new InVivo Therapeutics Holdings Corp positions in Q1 2016 and 8 closed out, a net change of +8 holders.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q1 2016 was Sabby Management, an estimated $3.11M added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q1 2016 was Wellington Management Group, an estimated $737K sold.

Based on aggregated 13F filings for Q1 2016.